WebApr 12, 2024 · As of last trade, Hikma Pharmaceuticals PLC (HIK:LSE) traded at 1,650.00, 40.49% above the 52 week low of 1,174.50 set on Oct 24, 2024. 52-week range Today 1,174.50 Oct 24 2024 2,137.00 Mar 25... Web102 rows · Hikma Pharmaceuticals PLC (HIK.L) Stock Historical Prices & Data - Yahoo Finance U.S. markets closed Hikma Pharmaceuticals PLC (HIK.L) LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)...
Did you know?
WebThe Hikma Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. WebHikma Pharmaceuticals Plc - ADR. HKMPY stock. $42.50. 2.41%. $7.07 B. 3.48%. $1.48-Overview - HKMPY. Overview. Ratings. Recommendation. Payouts. Div Growth. Capture Strategy. News & Research. Profile. Home Dividend Stocks Health Care Biotech Pharma Generic Pharma Hikma Pharmaceuticals Plc - ADR (HKMPY) Dividend Data
WebHIK: Hikma Pharmaceuticals PLC Stock Price Quote - London - Bloomberg US Edition Sign In Subscribe Live Now Bloomberg TV+ Business of Sports: Metaverse Virtual reality and sports seem... WebApr 12, 2024 · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms in North America, the Middle East, North Africa, and Europe.
WebApr 12, 2024 · HKMPF Stock Forecast, Price & News (Hikma Pharmaceuticals) Free Trial Research Tools My MarketBeat My Portfolio My Performance My Insights My Headlines My Calendar My Ratings My Insider Trades My Earnings My SEC Filings My Social My Newsletter My Portfolio Ideas My Account Calculators Dividend Calculator Dividend Yield … WebApr 5, 2024 · Jazz Pharmaceuticals Contacts: Investors: Kathee Littrell, Vice President, Investor Relations, Ireland, +353 1 634 7887, U.S., +1 650 496 2717; Media: Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations, Ireland, +353 1 …
WebHikma launches Icosapent Ethyl Capsules, 0.5g, in the US Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2024 financial results Notice of Annual General Meeting Friday 28 April 2024, 11.00 AM GMT, Sofitel London St James, 6 Waterloo Place, London SW1Y 4AN Investor insight
WebInvestments 21 Share Price $21.00 (As of Friday Closing) General Information Description Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. hilliard city schools district numberWebPrice To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Hikma Pharmaceuticals (HKMPF) ... Hikma Pharmaceuticals price target raised to 2,100 GBp from ... hilliard city schools budgetWebApr 13, 2024 · Hikma Pharmaceuticals Stock Up 1.6 % Shares of HIK opened at GBX 1,804.50 ($22.35) on Wednesday. The firm has a market cap of £3.98 billion, a P/E ratio of 2,651.49, a P/E/G ratio of 2.38 and a ... smart drawing blusherWebApr 12, 2024 · About Hikma Pharmaceuticals (OTCMKTS:HKMPY) Stock Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. hilliard city schools medication formWebApr 6, 2024 · Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst institutional investors who own 51% Simply Wall St Published April 06, 2024 Source: Shutterstock Key Insights Given the large stake in the stock by institutions, Hikma Pharmaceuticals' stock price might be vulnerable to their trading decisions smart doorbell camera display smartthingsWebApr 12, 2024 · Hikma Pharmaceuticals PLC announces that Riad Mishlawi, President of the Group's Injectables business, has been appointed Chief Executive Officer (CEO), effective 1 September 2024. Thereafter, Said Darwazah will step down as acting CEO and return to his role as Executive Chairman. As CEO, Riad will bring his deep knowledge of Hikma and the ... smart draw how toWebApr 12, 2024 · The London-based pharmaceutical company said it promoted Mishlawi from his current role as president of the group's Injectables business since 2011, and will bring his "deep knowledge of Hikma and the pharmaceutical industry", alongside a "strong track record" of delivering profitable growth and strategic expansion. hilliard city schools facility rental